CVSA

Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 462.29 M503.38 M487.03 M501.38 M 1.95 B Gross profit 261.12 M297.75 M275.7 M284.32 M 1.12 B Operating expenses 175.64 M186.63 M184.36 M225.24 M 771.87 M Selling/general/admin expenses 175.73 M182.79 M184.11 M188.09 M 730.72 M Research & development ———— — Operating income 85.48 M111.11 M91.34 M95.44 M 383.38 M Non-Operating Income, Total 4.97 M3.41 M464 K5.51 M 14.36 M Interest expense, net of interest capitalized 11.09 M10.92 M13.63 M9.8 M 45.44 M Non-Operating Income, excl. Interest Expenses -8.6 M-9.21 M-13.4 M-7.04 M -38.26 M Unusual income/expense 2.49 M1.7 M232 K2.76 M 7.18 M Pretax income 76.87 M101.9 M77.94 M88.4 M 345.12 M Equity in earnings ———— — Taxes 15.81 M25.73 M19.96 M16.24 M 77.74 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 61.06 M76.17 M57.98 M72.16 M 267.38 M Discontinued operations 770 K205 K-16.34 M-439 K -15.81 M Net income 61.83 M76.38 M41.64 M71.72 M 251.57 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 61.83 M76.38 M41.64 M71.72 M 251.57 M Basic earnings per share (Basic EPS) 1.712.141.212.12 7.18 Diluted earnings per share (Diluted EPS) 1.672.111.22.06 7.04 Average basic shares outstanding 36.11 M35.73 M34.28 M35.05 M — Diluted shares outstanding 37.06 M36.23 M34.78 M35.72 M — EBITDA 99.43 M125.59 M106.21 M118.55 M 449.78 M EBIT 85.48 M111.11 M91.34 M95.44 M 383.38 M Cost of revenue 201.17 M205.64 M211.33 M217.06 M 835.2 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 13.95 M14.48 M14.87 M23.1 M 66.41 M